March 5 (Reuters) - Chimerix CMRX.O:
JAZZ PHARMACEUTICALS TO ACQUIRE CHIMERIX, FURTHER DIVERSIFYING ONCOLOGY PORTFOLIO
CHIMERIX INC - DEAL VALUED AT $935 MILLION, OR $8.55 PER SHARE
CHIMERIX INC - JAZZ TO FUND TRANSACTION THROUGH EXISTING CASH AND INVESTMENTS
Source text: ID:nPn3n9k3Ga
Further company coverage: CMRX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.